Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dargelas
Alain M. Dargelas, Milpitas, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100179804 | Natural Language Assertion Processor - A method of processing natural language assertions (NLAs) can include identifying an NLA and then translating that NLA into a verification language assertion (VLA) using a natural language parser (NLP) and synthesis techniques. This VLA can be translated into an interpreted NLA (NLA*) using a VLA parser and pattern matching techniques. At this point, the process can allow user review of the NLA* and the NLA. When the user determines that the NLA* and the NLA are the same or have insignificant difference, then verification can be performed using the VLA. The results of the verification can then be back annotated on the NLA. In one fully-automatic embodiment, in addition to comparing the NLA and the NLA*, the VLA and a VLA* (generated from the NLA*) can be compared, thereby providing yet another test of accuracy for the user during verification. | 07-15-2010 |
| 20110234600 | Client/Server Waveform Viewer Using Bitmaps - Improving on the waveform viewing technology can advantageously address the industry's need for speedup and capacity of existing solution. As described herein, making data manipulation local and bounded can facilitate tremendous speedup. The waveform viewer can process data on-demand where the user explicitly specifies signals and a desired window (i.e. range). Operations including, but not limited to, zoom, pan, scan, etc. on the waveform viewer can be sent to the waveform servers in the form of a query containing the visualization parameters (e.g. number of pixels), which in turn compute bitmaps (or other waveform images) that are sent back to be displayed. | 09-29-2011 |
Frederic Dargelas, Brussels BE
| Patent application number | Description | Published |
|---|---|---|
| 20110275693 | Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives - The present invention relates to an immediate release formulation of pharmaceutical compounds. | 11-10-2011 |
Frédéric Dargelas, Pessac FR
| Patent application number | Description | Published |
|---|---|---|
| 20090220611 | Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same - The invention concerns microparticulate systems with modified release of oral active principle(s). The invention aims at providing a novel pharmaceutical with time-dependent and pH-dependent release mechanism, enabling: a) the latent period preceding the release of the active principle in the stomach; b) the pH triggering the release of the active principle in the intestine; c) the release speed of the active principle. This is achieved through the use of coated microparticles made from particles of active principle each coated with two coating films A and B. A comprises: film-forming (co)polymer (A1) insoluble in fluids of the gastrointestinal tract; ethylcellulose (co)polymer (A2) soluble in fluids of the gastrointestinal tract; plasticizing polyvinylpyrrolidone (A3); castor oil/optionally a surfactant and/or magnesium stearate lubricant (A4). B comprises a hydrophilic polymer (B1) bearing ionized groups with neutral pH (EUDRAGIT® L100-55) and a hydrophobic compound (B2) (LUBRITAB®). The invention also concerns medicines based on said microparticles. | 09-03-2009 |
| 20100092553 | ANTI-MISUSE MICROPARTICULATE ORAL PHARMACEUTICAL FORM - The present invention relates to solid microparticulate oral pharmaceutical forms whose composition and structure make it possible to avoid misuse of the pharmaceutical active principle (AP) they contain. | 04-15-2010 |
| 20110104266 | MULTIMICROPARTICULATE PHARMACEUTICAL FORMS FOR ORAL ADMINISTRATION - The object of the present invention is to minimize the risks of dose dumping associated with the concomitant consumption of alcohol and certain modified-release pharmaceutical or dietetic forms. | 05-05-2011 |
Frédéric Dargelas, Pessac FR
| Patent application number | Description | Published |
|---|---|---|
| 20110104266 | MULTIMICROPARTICULATE PHARMACEUTICAL FORMS FOR ORAL ADMINISTRATION - The object of the present invention is to minimize the risks of dose dumping associated with the concomitant consumption of alcohol and certain modified-release pharmaceutical or dietetic forms. | 05-05-2011 |